Annual Accounts Payable
$9.45 M
+$4.15 M+78.39%
30 June 2024
Summary:
Renovaro Biosciences annual accounts payable is currently $9.45 million, with the most recent change of +$4.15 million (+78.39%) on 30 June 2024. During the last 3 years, it has risen by +$9.13 million (+2847.19%). RENB annual accounts payable is now at all-time high.RENB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$11.40 M
+$1.95 M+20.67%
30 September 2024
Summary:
Renovaro Biosciences quarterly accounts payable is currently $11.40 million, with the most recent change of +$1.95 million (+20.67%) on 30 September 2024. Over the past year, it has increased by +$5.82 million (+104.42%). RENB quarterly accounts payable is now at all-time high.RENB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.4% | +104.4% |
| 3 y3 years | +2847.2% | +6735.9% |
| 5 y5 years | +1654.3% | +1715.6% |
RENB Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2847.2% | at high | +6735.9% |
| 5 y | 5 years | at high | +2847.2% | at high | +6735.9% |
| alltime | all time | at high | +2847.2% | at high | >+9999.0% |
Renovaro Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.40 M(+20.7%) |
| June 2024 | $9.45 M(+78.4%) | $9.45 M(+18.2%) |
| Mar 2024 | - | $7.99 M(+43.3%) |
| Dec 2023 | - | $5.58 M(+2.9%) |
| Sept 2023 | - | $5.42 M(+2.3%) |
| June 2023 | $5.30 M(+277.8%) | - |
| June 2023 | - | $5.30 M(+18.5%) |
| Mar 2023 | - | $4.47 M(-1.8%) |
| Dec 2022 | - | $4.56 M(-2.7%) |
| Sept 2022 | - | $4.68 M(+234.0%) |
| June 2022 | $1.40 M(+337.3%) | $1.40 M(+187.9%) |
| Mar 2022 | - | $487.00 K(+192.0%) |
| Dec 2021 | - | $166.80 K(-69.6%) |
| Sept 2021 | - | $547.90 K(+70.9%) |
| June 2021 | $320.60 K(-45.9%) | $320.60 K(-36.5%) |
| Mar 2021 | - | $504.90 K(+167.3%) |
| Dec 2020 | - | $188.90 K(-33.1%) |
| Sept 2020 | - | $282.40 K(-52.4%) |
| June 2020 | $592.90 K(+10.1%) | $592.90 K(+80.5%) |
| Mar 2020 | - | $328.40 K(-47.7%) |
| Dec 2019 | - | $628.00 K(+3.0%) |
| Sept 2019 | - | $609.60 K(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | $538.60 K(-5.8%) | $538.60 K(-57.6%) |
| Mar 2019 | - | $1.27 M(+68.5%) |
| Dec 2018 | - | $753.90 K(+5.7%) |
| Sept 2018 | - | $713.10 K(+24.7%) |
| June 2018 | $571.80 K(-14.7%) | $571.80 K(-36.4%) |
| Mar 2018 | - | $898.60 K(-3.8%) |
| Dec 2017 | - | $933.80 K(+109.9%) |
| Sept 2017 | - | $444.90 K(-33.6%) |
| June 2017 | $670.00 K(-43.5%) | $670.00 K(-45.5%) |
| Mar 2017 | - | $1.23 M(+15.4%) |
| Dec 2016 | - | $1.06 M(-1.1%) |
| Sept 2016 | - | $1.08 M(-9.1%) |
| June 2016 | $1.19 M(+34.9%) | $1.19 M(+49.1%) |
| Mar 2016 | - | $794.70 K(+27.5%) |
| Dec 2015 | - | $623.20 K(-30.2%) |
| Sept 2015 | - | $893.20 K(+8.5%) |
| June 2015 | $878.80 K(-4.9%) | - |
| Mar 2015 | - | $823.00 K(-10.9%) |
| Dec 2014 | $923.90 K | $923.90 K(+48.1%) |
| Sept 2014 | - | $624.00 K(-6.7%) |
| June 2014 | - | $668.90 K(+17.7%) |
| Mar 2014 | - | $568.20 K(>+9900.0%) |
| Dec 2011 | - | $400.00 |
FAQ
- What is Renovaro Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Renovaro Biosciences?
- What is Renovaro Biosciences annual accounts payable year-on-year change?
- What is Renovaro Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly accounts payable year-on-year change?
What is Renovaro Biosciences annual accounts payable?
The current annual accounts payable of RENB is $9.45 M
What is the all time high annual accounts payable for Renovaro Biosciences?
Renovaro Biosciences all-time high annual accounts payable is $9.45 M
What is Renovaro Biosciences annual accounts payable year-on-year change?
Over the past year, RENB annual accounts payable has changed by +$4.15 M (+78.39%)
What is Renovaro Biosciences quarterly accounts payable?
The current quarterly accounts payable of RENB is $11.40 M
What is the all time high quarterly accounts payable for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly accounts payable is $11.40 M
What is Renovaro Biosciences quarterly accounts payable year-on-year change?
Over the past year, RENB quarterly accounts payable has changed by +$5.82 M (+104.42%)